Model 1 (LR: 11.16, AUC: 0.646), utilizing a subset of clinicopathologic characteristics and conventional BC IHC estimates, selected Ki67% as an independent predictor of worse BCSS. This evidence concerns the gene MKI67 and breast cancer.